News stories about Semler Scientific (NASDAQ:SMLR) have trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Semler Scientific earned a daily sentiment score of 0.20 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 47.8855248442146 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Shares of Semler Scientific (NASDAQ SMLR) traded up 9.70% during midday trading on Wednesday, hitting $7.24. 3,080 shares of the stock were exchanged. The company’s market capitalization is $39.55 million. Semler Scientific has a 1-year low of $1.28 and a 1-year high of $7.24. The firm has a 50-day moving average of $4.92 and a 200-day moving average of $3.57.
Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Tuesday, October 31st. The medical equipment provider reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.08. The business had revenue of $3.61 million during the quarter, compared to analysts’ expectations of $2.92 million. On average, equities analysts expect that Semler Scientific will post ($0.36) EPS for the current year.
In related news, Director Herbert J. Semler sold 20,000 shares of the firm’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $3.37, for a total value of $67,400.00. Following the completion of the transaction, the director now directly owns 130,000 shares of the company’s stock, valued at $438,100. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.com-unik.info/2017/11/01/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-semler-scientific-smlr-share-price.html.
About Semler Scientific
Semler Scientific, Inc develops, manufactures and markets products and services that assist healthcare insurers and physician groups in evaluating and treating chronic diseases. The Company markets QuantaFlo and WellChec to its customers. QuantaFlo is an approximately four-minute in-office blood flow test.
What are top analysts saying about Semler Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Semler Scientific Inc and related companies.